Telix_Main_Logo (3).png
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
26 févr. 2024 16h27 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics...
Telix_Main_Logo (3).png
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
22 févr. 2024 03h51 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All...
Telix_Main_Logo (3).png
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
07 févr. 2024 16h43 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences,...
Telix_Main_Logo (3).png
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
22 janv. 2024 06h00 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the...
Telix_Main_Logo (3).png
Telix Announces Planned Registered Public Offering and Listing in the United States
04 janv. 2024 16h59 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix” or the “Company”) today announces that it is considering an initial public offering (“IPO”) of...
Telix_Main_Logo (3).png
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 16h55 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) --  Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO,...
20170406 Telix Logo.png
Telix Radiopharmaceutical Production Facility Buildout Commences
21 mars 2022 18h41 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to provide a material update on the development...
20170406 Telix Logo.png
EAU Updates Guidance for PSMA-PET Imaging
21 mars 2022 01h28 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, March 21, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the updated 2022 ‘Guidelines on Prostate...
20170406 Telix Logo.png
ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
07 mars 2022 17h37 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that ZIRCON (Zirconium in Renal Cancer Oncology,...
20170406 Telix Logo.png
Telix Enters Commercial Distribution Agreement for Illuccix® in Australia
15 févr. 2022 17h39 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a commercial distribution agreement with...